| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | +8.34% | -3.04% | +11.38% | +11.38% | — |
| 14d | 1 | +0.00% | -4.71% | -7.38% | +2.66% | +2.66% | — |
| 30d | 1 | +0.00% | -1.09% | -9.26% | +8.17% | +8.17% | — |
| 60d | 1 | +0.00% | -41.64% | -13.67% | -27.97% | -27.97% | — |
| 90d | 1 | +0.00% | -17.61% | -6.22% | -11.39% | -11.39% | — |
| 180d | 1 | +100.00% | +18.54% | -2.39% | +20.93% | +20.93% | — |
| 1y | 1 | +0.00% | -4.37% | +3.93% | -8.30% | -8.30% | — |
| 2y | 1 | +0.00% | -43.38% | +33.89% | -77.27% | -77.27% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 36,818 | $0.19 | $7.1K | 54,846 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,732 | — | — | 3,732 | Apr 7, 2026 | Apr 9, 2026 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 71,268 | — | — | 71,268 | Apr 7, 2026 | Apr 9, 2026 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 7,541 | $1.70 | $12.8K | 18,028 | Jun 30, 2025 | Jul 1, 2025 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Jun 23, 2025 | Jun 25, 2025 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 4,854 | $2.96 | $14.4K | 10,487 | Jun 28, 2024 | Jul 2, 2024 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 500,000 | — | — | 500,000 | Jun 24, 2024 | Jun 26, 2024 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 167 | $1.72 | $287 | 5,633 | Dec 29, 2023 | Jan 3, 2024 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 167 | $1.59 | $265 | 5,466 | Jun 30, 2023 | Jul 5, 2023 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,000 | $0.09 | $438 | 158,998 | Dec 30, 2022 | Jan 3, 2023 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 600,000 | $0.17 | $103.2K | 626,234 | Aug 17, 2022 | Aug 18, 2022 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,000 | $0.75 | $3.7K | 153,998 | Jun 30, 2022 | Jul 15, 2022 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | SALE CHIEF EXECUTIVE OFFICER | 100,000 | — | — | 70,000 | May 12, 2022 | May 16, 2022 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 100,000 | $1.00 | $100.0K | 148,998 | May 12, 2022 | May 16, 2022 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Mar 1, 2022 | Mar 3, 2022 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,623 | $1.66 | $6.0K | 48,998 | Dec 31, 2021 | Jan 3, 2022 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,000 | $1.95 | $9.7K | 45,375 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | SALE CHIEF EXECUTIVE OFFICER | 5,000 | — | — | 0 | Apr 23, 2021 | Apr 27, 2021 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 5,000 | $1.50 | $7.5K | 40,375 | Apr 23, 2021 | Apr 27, 2021 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,000 | $0.45 | $2.3K | 35,375 | Dec 31, 2020 | Jan 4, 2021 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Dec 30, 2020 | Jan 4, 2021 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,000 | $0.45 | $2.2K | 30,375 | Jun 30, 2020 | Jul 1, 2020 ↗ | View → |
| VTGN VISTAGEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Apr 23, 2020 | Apr 27, 2020 ↗ | View → |